Skip to main content
. 2022 Nov 16;13:1037566. doi: 10.3389/fimmu.2022.1037566

Figure 1.

Figure 1

Study design. Between January 2010 and December 2018, 1,080 patients were included in the study. Based on a TWCV of 30%, the patients were classified into high- or low-IPV groups. The RM and NRM groups were classified based on the CDR 1.05 ng•mg/mL. Finally, the patients were classified into four groups according to their TAC-IPV and RM/NRM status. CDR, concentration-to-dose ratio; HLA, human leukocyte antigen; IPV, intra-patient variability; NRM, non-rapid metabolizer; RM, rapid metabolizer; TAC-C0, tacrolimus trough level; TWCV, time-weighted coefficient variation.